Visualization and quantitation of epidermal growth factor receptor homodimerization and activation with a proximity

Keiichi Ota1, Taishi Harada1,2, Kohei Otsubo1

  • 1Research Institute for Diseases of The Chest, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.

Oncotarget
|October 27, 2017
PubMed
Abstract

Insights

A new proximity ligation assay (PLA) can detect epidermal growth factor receptor (EGFR) homodimers in non-small cell lung cancer (NSCLC). This method shows promise for quantifying activated EGFR in tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Epidermal growth factor receptor (EGFR) activation involves homodimerization and autophosphorylation.
  • EGFR activation is crucial for tyrosine kinase inhibitor sensitivity in certain cancers.
  • Clinical methods for visualizing and quantifying activated EGFR are lacking.

Purpose of the Study:

  • To establish a method for detecting and quantifying EGFR homodimers in clinical samples.
  • To assess the utility of proximity ligation assay (PLA) for visualizing activated EGFR.

Main Methods:

  • Proximity ligation assay (PLA) was employed to detect EGFR homodimers.
  • Assays were performed on non-small cell lung cancer (NSCLC) cell lines and patient tissue specimens.

Main Results:

  • PLA signals for EGFR homodimers were elevated in NSCLC with activating EGFR mutations compared to wild-type.
  • EGF stimulation and EGFR overexpression induced significant EGFR homodimerization.
  • EGFR homodimerization correlated with EGFR autophosphorylation in wild-type NSCLC cells.

Conclusions:

  • Proximity ligation assay (PLA) offers a novel approach for detecting and quantifying EGFR homodimers.
  • PLA has potential applications in NSCLC and other malignancies involving EGFR activation.

Related Concept Videos